top of page

PEER-REVIEWED PUBLICATIONS (> 3800 citations, h-index = 29)

https://scholar.google.com/citations?hl=en&user=kDli0S8AAAAJ&view_op=list_works&sortby=pubdate

(*Authors contributed equally, #corresponding author)

45. Gahyun Lee*, Juwon Baig*, and Sejin Son#, Emerging Mechanisms in Immunoadjuvant Design for Vaccine and Immunotherapy, Trends in   
       Pharmaceutical Sciences, 2024

44. Jutaek Nam*, April Kim*, Kidong Kim*, Jung Hyun Moon, Juwon Baig, May Phoo, James Moon# and Sejin Son#, Engineered Polysaccharides            for Controlling the Innate and Adaptive Immune Responses, Nature Reviews Bioengineering, 2024, Accepted

43. Aliya Sheik, Kugalur Shangmugam Ranjith, Seyed Majid Ghoreishian, Yujeong Yang, YongHyeon Park, Sejin Son, Young-Kyu Han, Yun Suk

        Huh, Green approach for the fabrication of dual-functional S/N doped graphene tagged ZnO nanograins for in vitro bioimaging and water     

        pollutant remediation, Environmental Pollution, 2024, https://doi.org/10.1016/j.envpol.2023.123077

42. Ivan Hardianto Suliman, Ki Dong Kim, Wei Hsuan Chen, Yu Bin Kim, Jeong Hyun Moon, Sejin Son#, Jutaek Nam#, Metal-Based Nanoparticles         for Cancer Metalloimmunotherapy, Pharmaceutics, 2023, https://doi.org/10.3390/pharmaceutics15072003

41. Deborah Lee, Seoyoon Song, Suheon Kim, Mina Lee, Eunsu Kim, Sunhee Yoon, Han-Ul Kim, Sejin Son, Hyun Suk Jung, Yun Suk Huh, Sun Min           Kim#, and Tae-Joon Jeon#, Multicomponent-Loaded Vesosomal Drug Carrier for Controlled and Sustained Compound Release, 

       Biomacromolecules2023, https://doi.org/10.1021/acs.biomac.3c00528

40. Isra Rana, Jaeeun Oh, Juwon Baig, Jung Hyun MoonSejin Son#, Jutaek Nam#, Nanocarriers for cancer nano-immunotherapy, 
        Drug Delivery and Translational Research, 13, 1936-1954, 2023, https://doi.org/10.1007/s13346-022-01241-3

39. Sejin Son*# Jutaek Nam*, April S. Kim, Jinsung Ahn, Kyung Soo Park, May Thazin Phoo, Brett Sherren, Weiping Zou, Soo-Hong Lee, Omid C.
       Farokhzad, Jinjun Shi, James J. Moon#, Induction of T-helper-17-cell-mediated anti-tumour immunity by pathogen-mimicking polymer
       nanoparticles, Nature Biomedical Engineering, https://doi.org/10.1038/s41551-022-00973-4 
       Highlighted in Nature BME News & Views, "TH17 cells boosted by nanoparticle-bound fungal motifs",

        https://doi.org/10.1038/s41551-022-00992-1, by Mihai G. Netea & Williem J.M. Mulder

Before INHA University ----------------------------------------------------------------------------------------------------------------------------------------------------

38. Nam J*, Son S*, Park K, Moon JJ, Photothermal therapy combined with neoantigen cancer vaccination for effective immunotherapy against
       large established tumors and distant metastasis, 2021, 2100093, Advanced Therapeutics.

37. Park K, Nam J, Son S, Moon JJ, Personalized combination nano-immunotherapy for robust induction and tumor infiltration of CD8+ T cells,
       2021, Biomaterials, 274, 120844, Biomaterials.

36. Park K, Bazzill J, Son S, Nam J, Shin SW, Stuckey J, Meagher J, Song J, Montefiori DC, LaBranche CC, Smith J, Xu J, and Moon JJ, Lipid-
       based vaccine nanoparticles for induction of humoral immune responses against HIV-1 and SARS-CoV-2, 2021, 330, 529-539, Journal of
       Controlled Release.

35. Nam J*, Son S*, Park K, Moon JJ, Modularly programmable nanoparticle vaccine based on polyethyleneimine for personalized cancer
       immunotherapy, 2021, 8 (5), 2002577, Advanced Science.

34. Scheetz L, Kadiyala P, Sun X, Son S, Najafabadi A, Aikins M, Lowenstein P, Schwendeman A, Castro M, and Moon JJ. Synthetic high-density
       lipoprotein nanodiscs for personalized immunotherapy against gliomas, 26, 16, 4369-4380, 2020, Clinical Cancer Research.

33. Son S*, Nam J*, Zenkov I, Ochyl LJ, Xu Y, Scheetz L, Shi J, Farokhzad OC# Moon JJ#. Sugar-Nanocapsules imprinted with Microbial
       Molecular Patterns for mRNA Vaccination, 2020, 20, 3, 1499-1509, Nano Letters.

32. Nam J*, Son S*, Park KS, Moon JJ. Cancer nanomedicine for the new era of combination cancer therapy, 4 (6), 398-414, 2019, Nature Review
       Materials.

31. Kuai R*, Yuan W*, Son S, Nam J, Xu Y, Fan Y, Schwendeman A, and Moon JJ. Elimination of established tumors with nanodisc-based
        combination chemoimmunotherapy, 4, eaao1736, 2018,  Science Advances.

30. Nam J*, Son S*, Ochyl LJ, Kuai R, Schwendeman A, Moon JJ. Chemo-photothermal therapy combination elicits anti-tumor immunity against
       advanced metastatic cancer, 9, 1074, 2018, Nature Communication.

29.  You DG, Yoon HY, Jeon S, Um W, Son S, Park JH, Kwon IC, Kim K. Deep tissue penetration of nanoparticles using pulsed-high intensity
        focused ultrasound, 4, 30, 2017, Nano convergence.
28.  Nam J, Son S, JJ Moon. Adjuvant-loaded spiky gold nanoparticles for activation of innate immune  cells, 10, 341-355, 2017, Cellular and
        molecular bioengineering.

27.  Son S*, Kim N*, You DG, Yoon HY, Yhee JY, Kim K, Kwon IC, Kim SH. Antitumor therapeutic application of self-assembled RNAi-AuNP
        nanoconstructs: Combination of VEGF-RNAi and photothermal ablation, 7, 9, 2017, Theranostics.
26.  Min HS*, Son S*, You DG, Lee TW, Lee S, Lee J, Han MH, Park JH, Kim SH, Choi K, Park K, Kim,  K, Kwon IC. Chemical gas-generating
         nanoparticles for tumor-targeted ultrasound imaging and ultrasound-triggered drug delivery. 108, 57, 2016, Biomaterials.
25.  Han H*, Son S*, Son S, Kim N, Yhee JY, Lee JH, Choi JS, Joo CK, Lee H, Kim WJ, Kim SH, Kwon, IC, Kim H, Kim K. Reducible polyethylenimine
         nanoparticles for efficient siRNA delivery in corneal neovascularization therapy. 16, 11, 1583, 2016, Macromolecular Bioscience. Highlighted
         in Cover Picture.

24.  You DG, Deepagan VG, Um W, Jeon S, Son S, Chang H, Yoon HI, Cho YW, Swierczewska M, Lee S, Pomper MG, Kwon IC, Kim K, Park JH.
          ROS-generating TiO2 nanoparticles for non-invasive sonodynamic therapy of cancer, 6, 23200, 2016, Scientific Reports.
23.  Min HS, You DG, Son S, Jeon S, Yhee J, Park JH, Lee S, Kwon IC, Kim K. Echogenic glycol chitosan nanoparticles for ultrasound-triggered
         cancer theranostics. 5, 12, 1402-1418, 2015, Theranostics. Highlighted in Cover Picture.
22.   Yhee JY, Son S, Lee H, Kim K. Nanoparticle-based combination therapy for cancer treatment. 21, 22, 3158-66, 2015, Current               
         Pharmaceutical Design.

21.   Yhee JY, Song S, Lee SJ, Park S, Kim K, Kim MG, Son S, Koo H, Kwon IC, Jeong JH, Jeong SY, Kim SH, Kim K. Cancer-targeted MDR-1 siRNA
         delivery using self-cross-linked glycol chitosan nanoparticles to overcome drug resistance. 198, 28, 1-9, 2014, Journal of Controlled
         Release.

20.   Yoon HY*, Son S*, Lee SJ, You DG, Yhee JY, Park JH, Swierczewska M, Lee S, Kwon IC, Kim SH, Kim K, Promper MG. Glycol chitosan
         nanoparticles as highly specialized cancer therapeutic vehicles: Sequential delivery of doxorubicin and Bcl-2 siRNA, 4, 6878, 2014,
         Scientific Reports.
19.   Son S*, Min HS*, You DG, Kim BS, Kwon IC, Echogenic nanoparticles for ultrasound technologies; evolution from diagnostic imaging
         modality to multimodal theranostic agent, 9, 4, 525-540, 2014, Nano Today.
18.   Son S*, Nam J*, Kim J, Kim S, Kim WJ. i-motif-driven Au nanomachines in programmed siRNA delivery for gene-silencing and photothermal
         ablation, 8, 6, 5574-5584, 2014, ACS Nano.
17.   Yhee JY, Lee SJ, Lee S, Song S, Min HS, Kang, SW, Son S, Jeong SY, Kim SH, Kim K. Tumor-targeting Transferrin Nanoparticles for Systemic
         Polymerized siRNA Delivery in Tumor-bearing Mice, 24, 11, 1850-1860, 2013, Bioconjugate Chemistry.
16.   Min HS*, Son S*, Lee TW, Koo, H, Yoon HY, Na JH, Choi Y, Park JH, Lee J, Han M, Park RW, Kim IS, Jeong SY, Kim SH, Kwon IC, Kim K. Liver-
         specific and echogenic hyaluronic acid nanoparticles facilitating liver cancer discrimination, 23, 44, 5518-5529, 2013, Advanced Functional
          Materials. Highlighted in Cover Picture.

15.   Lee SJ*, Son S*; Yhee JY, Choi K, Kwon IC, Kim SH, Kim K. Structural modification of siRNA for efficient gene silencing, 31, 5, 491-503, 2013,
         Biotechnology Advances.
14.   Park J, Singha K, Son S, Kim J, Namgung R, Yun CO, Kim WJ. A Review of RGD-functionalize non-viral gene delivery vectors for cancer
         therapy, 19, 741-748, 2012, Cancer Gene Therapy.
13.   Son S*, Namgung R, Kim J, Singha K, Kim WJ. Bioreducible polymers for gene silencing and delivery, 45, 1100-1112, 2012, Account of
         Chemical Research.

12.   Joung YK*, Son S*, Jang JY, Kwon MH, Park KD. Sustained cytoplasmic delivery and anti-viral effect of PLGA nanoparticles carrying a
          nucleic acid-hydrolyzing monoclonal antibody, 29, 932-942, 2012, Pharmaceutical Research.
11.   Son S*, Kim G, Singha K, Park S, Ree M, Kim WJ. “Artificial Cell Membrane-mimicking Nanostructure Facilitates Efficient Gene Delivery
         through Fusogenic Interaction with the Plasma Membrane of Living Cells, 7, 2991-2997, 2011, Small. Highlighted in the frontispiece.
10.   Che HL, Muthiah M, Ahn Y, Son S, Kim WJ, Seonwoo H, Chung JH, Cho CS, Park IK. Biodegradable Particulate Delivery of Vascular
         Endothelial Growth Factor Plasmid from Polycaprolactone/Polyethylenimine Electrospun Nanofibers for the Treatment of Myocardial
         Infarction, 11, 1-5, 2011, Journal of Nanoscience and Nanotechnology.
9.     Hwang DW, Son S, Jang J, Youn H, Lee S, Lee D, Lee YS, Jeong JM, Kim WJ, Lee DS. A brain-targeted rabies virus glycoprotein-disulfide
         linked PEI nanocarrier for delivery of neurogenic microRNA, 32, 4968-4975, 2011. Biomaterials. 
8.     Garripelli VK, Kim JK, Son S, Kim WJ, Repka MA, Jo S. Matrix metalloproteinase-sensitive thermogelling polymer for bioresponsive local drug
          delivery, 7, 1984-1992, 2011, Acta Biomaterialia.
7.     Son S*, Hwang DW, Singha K, Jeong JH, Park TG, Lee DS, Kim WJ. RVG peptide tethered bioreducible polyethylenimine for gene delivery to
          brain, 155, 18-25, 2011, Journal of Controlled Release.
6.     Yang SY*, Son S*, Jang S, Kim H, Jeon G, Kim WJ, Kim JK. DNA-functionalized nanochannels for SNP detection, 11, 1032-1035, 2011, Nano
         Letters.
 
5.     Son S*, Singha K, Kim WJ. Bioreducible BPEI-SS-PEG-cNGR polymer as a tumor targeted nonviral gene carrier, 31, 6344-6354, 2011,
         Biomaterials.
4.     Kim G, Rho Y, Park S, Kim H, Son S, Kim H, Kim IJ, Kim JR, Kim WJ, Ree M. The biocompatibility of self-assembled brush polymers bearing
         glycine derivatives, 31, 3816-3826, 2010, Biomaterials.
3.     Son S*, Kim WJ. Biodegradable nanoparticles modified by branched polyethylenimine for plasmid DNA delivery, 31, 133-143, 2010,
         Biomaterials.
2.     Namgung R, Nam S, Kim SK, Son S, Singha K, Kwon JS, Ahn Y, Jeong MH, Park IK, Garripelli VK, Jo S, Kim WJ. An acid-labile temperature-   
         responsive sol-gel reversible polymer for enhanced gene delivery to the myocardium and skeletal muscle cells, 30, 5225-5233, Biomaterials.
1.     Son S*, Lee WR, Joung YK, Kwon MH, Kim YS, Park KD. Optimized stability retention of a monoclonal antibody in the PLGA nanoparticles,
         368,178-185, 2009, International Journal of Pharmaceutics

bottom of page